Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
J Am Coll Cardiol. 2012 Feb 14;59(7):681-7. doi: 10.1016/j.jacc.2011.11.011.
The purpose of this study was to determine whether the timing of the most recent cardiac implantable electronic device (CIED) procedure, either a permanent pacemaker or implantable cardioverter-defibrillator, influences the clinical presentation and outcome of lead-associated endocarditis (LAE).
The CIED infection rate has increased at a time of increased device use. LAE is associated with significant morbidity and mortality.
The clinical presentation and course of LAE were evaluated by the MEDIC (Multicenter Electrophysiologic Device Cohort) registry, an international registry enrolling patients with CIED infection. Consecutive LAE patients enrolled in the Multicenter Electrophysiologic Device Cohort registry between January 2009 and May 2011 were analyzed. The clinical features and outcomes of 2 groups were compared based on the time from the most recent CIED procedure (early, <6 months; late, >6 months).
The Multicenter Electrophysiologic Device Cohort registry entered 145 patients with LAE (early = 43, late = 102). Early LAE patients presented with signs and symptoms of local pocket infection, whereas a remote source of bacteremia was present in 38% of patients with late LAE but only 8% of early LAE (p < 0.01). Staphylococcal species were the most frequent pathogens in both early and late LAE. Treatment consisted of removal of all hardware and intravenous administration of antibiotics. In-hospital mortality was low (early = 7%, late = 6%).
The clinical presentation of LAE is influenced by the time from the most recent CIED procedure. Although clinical manifestations of pocket infection are present in the majority of patients with early LAE, late LAE should be considered in any CIED patient who presents with fever, bloodstream infection, or signs of sepsis, even if the device pocket appears uninfected. Prompt recognition and management may improve outcomes.
本研究旨在确定心脏植入式电子设备(CIED)程序(永久性起搏器或植入式心律转复除颤器)的最近一次时间是否会影响与导联相关的心内膜炎(LAE)的临床表现和结果。
随着设备使用量的增加,CIED 感染率有所增加。LAE 与较高的发病率和死亡率相关。
通过 MEDIC(多中心电生理设备队列)登记处评估 LAE 的临床表现和病程,该国际登记处招募了 CIED 感染患者。分析 2009 年 1 月至 2011 年 5 月期间多中心电生理设备队列登记处连续收治的 LAE 患者。根据最近一次 CIED 操作的时间(早期,<6 个月;晚期,>6 个月),比较两组患者的临床特征和结局。
多中心电生理设备队列登记处纳入了 145 例 LAE 患者(早期=43 例,晚期=102 例)。早期 LAE 患者表现为局部口袋感染的体征和症状,而晚期 LAE 中有 38%的患者存在来自远处的菌血症源,但早期 LAE 中仅有 8%(p<0.01)。早期和晚期 LAE 中最常见的病原体均为葡萄球菌属。治疗方法包括移除所有硬件和静脉应用抗生素。院内死亡率较低(早期=7%,晚期=6%)。
LAE 的临床表现受最近一次 CIED 操作时间的影响。尽管早期 LAE 患者大多数存在口袋感染的临床表现,但任何出现发热、血流感染或败血症体征的 CIED 患者均应考虑晚期 LAE,即使设备口袋似乎未受感染。及时识别和处理可能会改善结局。